Alerts will be sent to your verified email
Verify Email
AARTIPHARM
|
Aarti Pharmalabs
|
Shilpa Medicare
|
Supriya Lifescience
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.05 % | 5.0 % | 23.4 % |
|
5yr average Equity Multiplier
|
1.39 | 1.64 | 1.25 |
|
5yr Average Asset Turnover Ratio
|
0.58 | 0.39 | 0.68 |
|
5yr Avg Net Profit Margin
|
8.95 % | 7.72 % | 25.52 % |
|
Price to Book
|
4.1 | 3.37 | 5.55 |
|
P/E
|
30.64 | 71.94 | 31.08 |
|
5yr Avg Cash Conversion Cycle
|
94.46 Days | 76.54 Days | -10.96 Days |
|
Inventory Days
|
94.9 Days | 105.79 Days | 56.1 Days |
|
Days Receivable
|
94.46 Days | 113.53 Days | 57.43 Days |
|
Days Payable
|
76.47 Days | 120.58 Days | 113.66 Days |
|
5yr Average Interest Coverage Ratio
|
12.05 | 11.52 | 60.74 |
|
5yr Avg ROCE
|
12.13 % | 6.65 % | 30.51 % |
|
5yr Avg Operating Profit Margin
|
15.5 % | 17.76 % | 36.15 % |
|
5 yr average Debt to Equity
|
0.16 | 0.44 | 0.06 |
|
5yr CAGR Net Profit
|
n/a | -27.23 % | 8.75 % |
|
5yr Average Return on Assets
|
6.11 % | 3.1 % | 17.81 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.72 % | 44.23 % | 68.3 % |
|
Share Pledged by Promoters
|
0.01 % | 7.92 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.26 % | -5.78 % | 0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-4.21 % | 3.04 % | -2.44 % |
|
Aarti Pharmalabs
|
Shilpa Medicare
|
Supriya Lifescience
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Customer Segment
|
Customer Segment
|
-
|
-
|